Treatment access and disparities in chemotherapy utilization among very elderly patients with metastatic NSCLC: A SEER-based quality of care analysis.
185 Background: Equitable access to systemic therapy is a measurable indicator of quality oncologic care, yet very elderly patients with metastatic non-small cell lung cancer (NSCLC) remain undertreated and underrepresented in clinical trials. The evolution of targeted therapies and immune checkpoint inhibitors...